Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Am J Infect Control. 2017 May 11;45(9):990–994. doi: 10.1016/j.ajic.2017.03.023

Table 3.

Multi-drug Resistant Organisms (MDROs) Detected, by Study Phase

Infections, Bath Basin Phase (rate/1000 patient days)
N=7981 patient days
Infections, Washcloth Phase (rate/1000 patient days)
N=8053 patient days
IRR (95% CI) p
Total MDROs 40 (5.0) 25 (3.1) 0.62 (0.36–1.05) 0.06
Methicillin-resistant Staphylococcus aureus 12 (1.5) 12 (1.5) 0.99 (0.41–2.41) 0.98
Vancomycin-resistant Enterococcus spp 5 (0.6) 2 (0.2) 0.39 (0.04–2.42) 0.28
Acinetobacter baumannii 7 (0.9) 2 (0.2) 0.28 (0.03–1.49) 0.11
Extended-spectrum beta-lactamase producing Klebsiella pneumonia 3 (0.4) 2 (0.2) 0.66 (0.06–5.77) 0.68
Pseudomonas aeruginosa 13 (1.6) 7 (0.9) 0.53 (0.18–1.44) 0.18

IRR: Incidence Rate Ratio.